Sign inJoin waitlistJoin the waitlist

HY

Hassan Yasin

Physician · University of Louisville School of Medicine

Credentials: · · · · ·

History

University of Louisville School of Medicine
2022–Present

H. Lee Moffitt Cancer Center and Research Institute
2021–2022
Hematology and Medical Oncology
Marshall University School of Medicine
2018–2021
Internal Medicine
Charleston Area Medical Center
2015–2018
Dow University of Health Sciences
2007–2011

Research

Immunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator
Case report · Journal of Investigative Medicine High Impact Case Reports · 2021 · First of 6 authors · Corresponding · 7 citations
Acute Myocardial Infarction in Young Systemic Lupus Erythematosus Patient with Normal Coronary Arteries
Case report · Cureus · 2017 · 6 citations
Diagnostic Pearls and Clinical Implications of Prekallikrein Deficiency
Case report · Cureus · 2020 · First of 3 authors · Corresponding · 4 citations

AF
Ali Farooq
4 papers · 4 as a resident
WA
Waseem Amjad
3 papers · 3 as a resident
Hesham Mohamed
2 papers
MP
Muhammad Pervaiz
2 papers
YL
Yehuda Lebowicz
2 papers
AU
Aman Ullah
1 paper
Ata Bajwa
1 paper · 1 as a fellow
FK
Farhad Khimani
1 paper
Farman Ali
1 paper
Fatima Ahmed
1 paper · 1 as a resident
JD
Jennifer Dotson
1 paper · 1 as a fellow
JC
Ju Chao
1 paper

Clinical trials

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2026–2038
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Site PI · Recruiting · Phase 3
Eastern Cooperative Oncology Group
2025–2075
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Site PI · Recruiting · Phase 2
Allogene Therapeutics
2024–2032
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2038